Louisiana pursues new purchasing model for HCV drugs

Louisiana wants to test a "subscription" style drug payment model for HCV drugs, and some companies may be up for it.

Under the model, the state would pay an HCV

Read the full 296 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE